Irish Times – Irish pharma company closes $64m financing round
Please link to the article by Charlie Taylor below which was posted in May 2018 by irishtimes.com/business website.
Sigmoid Pharma – now known as Sublimity Therapeutics has closed an enormous $64m round of financing. This large investment is to fund the clinical development of a drug to treat patients with moderate to severe ulcerative colitis. The drug is a soluble formulation which has been indicated as a safe, effective treatment for several inflammatory diseases including psoriasis and Crohn’s disease.
You can access further information reading the full article by clicking on the button below.